SS
SSKN
STRATA Skin Sciences, Inc.
$0.1600
+23.08%
No data for this timeframe.
Vol
Inst. Holders3 funds
Inst. Value$101.2K
Inst. Activity0 buys / 3 sells
Reddit Sentiment67° Warm
SEC Reports1
Exchange OTC·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001051514·Prev Close $0.1300
Recent Activity
Mar 2, 2026
SEC
STRATA Skin Sciences, Inc. (SSKN) has filed Form 15-12G to terminate the registration of its Common Stock under Section
15-12G — Impact 7/10
Inst.
RENAISSANCE TECHNOLOGIES LLC — TRIM
63,830 shares ($80.4K)
Inst.
VANGUARD GROUP INC — TRIM
16,375 shares ($20.6K)
May 18, 2026
other
New Peer-Reviewed Publication Confirms Unprecedented Response Rates for STRATA’s Excimer Laser Combined with JAK Inhibitors in Pediatric Vitiligo
Multicenter prospective RCT published in JAAD confirms superiority of XTRAC® Excimer Laser plus oral
Analyst Ratings
3Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Feb 27, 2025 | Maxim Group | INITIATE | Buy |
| May 16, 2023 | CG Capital | REITERATE | Outperform |
| Nov 3, 2020 | HC Wainwright & Co. | UPGRADE | Neutral → Buy |
| Mar 17, 2020 | HC Wainwright & Co. | DOWNGRADE | Buy → Neutral |
| Dec 9, 2019 | Ladenburg Thalmann | INITIATE | Buy |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $80.4K | TRIM |
| VANGUARD GROUP INC | $20.6K | TRIM |
| BANK OF AMERICA CORP | $155.00 | TRIM |
Reddit Sentiment
67°
Warm
Bearish
Neutral
Bullish
3 institutional holders with $101.2K total value (80,328 shares) as of 2025-Q4. Top holders: RENAISSANCE, VANGUARD, BANK. Net selling activity: 3 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | 63,830 | $80.4K | 79.5% | TRIM -37.1% |
| 2 | VANGUARD GROUP INC | 16,375 | $20.6K | 20.4% | TRIM -30.5% |
| 3 | BANK OF AMERICA CORP /DE/ | 123 | $155.00 | 0.2% | TRIM -36.3% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 101,530 | 63,830 | -37.1% | $80.4K | 2025-Q4 |
| VANGUARD GROUP INC | TRIM | 23,545 | 16,375 | -30.5% | $20.6K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | TRIM | 193 | 123 | -36.3% | $155.00 | 2025-Q4 |
| VANGUARD GROUP INC | TRIM | 84,632 | 23,545 | -72.2% | $48.5K | 2025-Q3 |
| UBS Group AG | NEAR_EXIT | 7,310 | 370 | -94.9% | $762.00 | 2025-Q3 |
| UBS Group AG | TRIM | 10,954 | 7,310 | -33.3% | $16.7K | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 21 | 197 | +838.1% | $451.00 | 2025-Q2 |
| CITADEL ADVISORS LLC | ADD | 21,852 | 31,222 | +42.9% | $90.2K | 2024-Q4 |
| UBS Group AG | ADD | 9,248 | 13,405 | +45.0% | $39.0K | 2024-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
1 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 0 neutral. Avg impact: 7.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Feb 2025): 88% buy across 8 analysts — 3 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2026-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2025-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
6 analyst firms have rated this stock: 1 upgrades, 1 downgrades, 4 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Feb 27, 2025 | Maxim Group | INITIATE | — | Buy |
| May 16, 2023 | CG Capital | REITERATE | — | Outperform |
| Nov 3, 2020 | HC Wainwright & Co. | UPGRADE | Neutral | Buy |
| Mar 17, 2020 | HC Wainwright & Co. | DOWNGRADE | Buy | Neutral |
| Dec 9, 2019 | Ladenburg Thalmann | INITIATE | — | Buy |
| Nov 21, 2019 | Oppenheimer | INITIATE | — | Outperform |
| Dec 10, 2018 | Northland Capital Markets | INITIATE | — | Outperform |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Apr 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Mar 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Feb 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Jan 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
67°
Warm
Bearish
Neutral
Bullish
5 mentions
3 bullish
0 bearish
3 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Feb 19, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Feb 9, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Feb 9, 2026 | 3 | 57° Neutral | 1 | 0 | 3 |
Recent Reddit Threads
May 18, 2026
other
New Peer-Reviewed Publication Confirms Unprecedented Response Rates for STRATA’s Excimer Laser Combined with JAK Inhibitors in Pediatric Vitiligo
Multicenter prospective RCT published in JAAD confirms superiority of XTRAC® Excimer Laser plus oral JAK inhibitors over tacrolimus combination therap
May 12, 2026
earnings_calendar
SSKN Q1 2026 Earnings Scheduled — 2026-05-12
Mar 25, 2026
earnings_calendar
SSKN Q4 2025 Earnings After Market Close — 2026-03-25